SitemapImpressumDatenschutzerklärungdeutschenglish
MHH Logo

Hematology, Hemostasis, Oncology and Stem Cell Transplantation

Professor Dr. med. Arnold Ganser, Director of the Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation


Professor Dr. med. Arnold Ganser is an outstanding specialist in hematology, hemostasis, oncology and stem cell transplantation.
Professor Ganser has been head of the Department since 1995.
He is chairman of the German-Austrian AML Trial Group (AMLSG), the German MDS Trial Group and 2008 chairman of the International Members Committee of the American Society of Hematology.
He is also a member of the Communications and the Awards Committees of the American Society of Hematology. Furthermore, he is editor-in-chief of the Annals of Hematology.

Clinical Profile

The Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation of Hannover Medical School is a nationally and internationally known institution with more than 50 physicians, psychologists, scientists, and many additional specialists including nurses for inpatient and outpatient care, laboratory technicians, documentalists, trial managers, and secretarial and administrative personnel.

Our Department has a hematologic-oncologic intensive care unit (28  beds), a ward for bone marrow and stem cell transplantation in adults (20 beds), treatment facilities in an interdisciplinary oncology unit (5 beds), an outpatient unit for chemo- and immunotherapy and transfusions (12 treatment chairs), several highly specialized outpatient clinics, laboratories for hematology, hemostasis, cytology and FACS analysis of blood and bone marrow cells, and molecular genetics, as well as several research laboratories.
All wards fulfill the highest criteria for infection prophylaxis with high-efficiency air filtration and positive pressure air conditioning.

Our patients receive optimal individual diagnostic work-ups and treatment carried out in cooperation with all the other medical and surgical disciplines at the MHH according to current medical guidelines.
With the most sophisticated diagnostic tools and regular meetings of the tumor board we design individual therapies for each patient to achieve the best treatment results possible: recovery, extension of life of a good quality, pain control.

Areas of specialization of Professor Gansers' Department:

  • Acute myeloid leukemia
  • Chronic myeloid leukemia
  • Acute lymphatic leukemia
  • Chronic lymphatic leukemia
  • Non-Hodgkin lymphoma
  • Hodgkin´s disease
  • Multiple myeloma
  • Myelodysplastic syndromes
  • Myeloproliferative diseases
  • Anemia and thrombocytopenia

     
  • Metastatic testicular cancer
  • Bone and soft-tissue sarcoma
  • Metastatic solid tumors

     
  • Hemophilia
  • Inborn and acquired hemorrhagic disorder

     
  • Internal and hematological diagnostics
  • Multidisciplinary oncologic therapies
  • Oncologic therapies/chemotherapy
  • Bone marrow and hemopoietic stem cell transplantation 

Scientific Profile

For many years, Professor Ganser's Department of Hematology, Hemostasis, Oncology and Stem Cell Transplantation has been very successful in research, as is indicated by the volume of its grant funding and the quality of its publications.

Scientists of different disciplines work together in the Department, which has an excellent international reputation.
The purpose of our research is the continuous improvement of treatment results for our patients based on a rapid transfer from bench to bedside.

The Department offers patients the chance of treatment with the most recent and promising new methods and medication within national and international clinical trials.

 

Homepage Department of Hematoloy, Hemostasis, Oncology and Stem Cell Transplantation